India’s Bharat Biotech says its Covaxin booster dose offers long-term protection
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called Covaxin during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, Jan. 16, 2021. (REUTERS)
India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.
The company said a booster dose was given to trial participants six months after they received their second dose.
Your subscription could not be saved. Please try again.
Your subscription has been successful.
READ NEXT
EDITORS' PICK
